PortfoliosLab logo
QLENX vs. CLOI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between QLENX and CLOI is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

QLENX vs. CLOI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AQR Long-Short Equity N (QLENX) and VanEck CLO ETF (CLOI). The values are adjusted to include any dividend payments, if applicable.

20.00%40.00%60.00%80.00%NovemberDecember2025FebruaryMarchApril
87.85%
22.21%
QLENX
CLOI

Key characteristics

Sharpe Ratio

QLENX:

2.38

CLOI:

1.43

Sortino Ratio

QLENX:

3.02

CLOI:

1.78

Omega Ratio

QLENX:

1.47

CLOI:

1.62

Calmar Ratio

QLENX:

3.24

CLOI:

1.80

Martin Ratio

QLENX:

14.51

CLOI:

14.59

Ulcer Index

QLENX:

1.58%

CLOI:

0.40%

Daily Std Dev

QLENX:

9.69%

CLOI:

4.08%

Max Drawdown

QLENX:

-39.59%

CLOI:

-3.25%

Current Drawdown

QLENX:

-0.47%

CLOI:

-0.62%

Returns By Period

In the year-to-date period, QLENX achieves a 9.81% return, which is significantly higher than CLOI's 0.98% return.


QLENX

YTD

9.81%

1M

1.18%

6M

17.33%

1Y

22.59%

5Y*

22.44%

10Y*

11.21%

CLOI

YTD

0.98%

1M

-0.08%

6M

2.24%

1Y

6.10%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


QLENX vs. CLOI - Expense Ratio Comparison

QLENX has a 5.18% expense ratio, which is higher than CLOI's 0.40% expense ratio.


Expense ratio chart for QLENX: current value is 5.18%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
QLENX: 5.18%
Expense ratio chart for CLOI: current value is 0.40%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
CLOI: 0.40%

Risk-Adjusted Performance

QLENX vs. CLOI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QLENX
The Risk-Adjusted Performance Rank of QLENX is 9494
Overall Rank
The Sharpe Ratio Rank of QLENX is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of QLENX is 9292
Sortino Ratio Rank
The Omega Ratio Rank of QLENX is 9292
Omega Ratio Rank
The Calmar Ratio Rank of QLENX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of QLENX is 9696
Martin Ratio Rank

CLOI
The Risk-Adjusted Performance Rank of CLOI is 9292
Overall Rank
The Sharpe Ratio Rank of CLOI is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOI is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CLOI is 9797
Omega Ratio Rank
The Calmar Ratio Rank of CLOI is 9292
Calmar Ratio Rank
The Martin Ratio Rank of CLOI is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

QLENX vs. CLOI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AQR Long-Short Equity N (QLENX) and VanEck CLO ETF (CLOI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for QLENX, currently valued at 2.38, compared to the broader market-1.000.001.002.003.00
QLENX: 2.38
CLOI: 1.43
The chart of Sortino ratio for QLENX, currently valued at 3.02, compared to the broader market-2.000.002.004.006.008.00
QLENX: 3.02
CLOI: 1.78
The chart of Omega ratio for QLENX, currently valued at 1.47, compared to the broader market0.501.001.502.002.503.00
QLENX: 1.47
CLOI: 1.62
The chart of Calmar ratio for QLENX, currently valued at 3.24, compared to the broader market0.002.004.006.008.0010.00
QLENX: 3.24
CLOI: 1.80
The chart of Martin ratio for QLENX, currently valued at 14.51, compared to the broader market0.0010.0020.0030.0040.0050.00
QLENX: 14.51
CLOI: 14.59

The current QLENX Sharpe Ratio is 2.38, which is higher than the CLOI Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of QLENX and CLOI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.007.00NovemberDecember2025FebruaryMarchApril
2.38
1.43
QLENX
CLOI

Dividends

QLENX vs. CLOI - Dividend Comparison

QLENX's dividend yield for the trailing twelve months is around 6.49%, which matches CLOI's 6.45% yield.


TTM20242023202220212020201920182017201620152014
QLENX
AQR Long-Short Equity N
6.49%7.13%21.14%14.09%0.00%1.59%0.00%6.09%8.91%2.87%4.91%7.97%
CLOI
VanEck CLO ETF
6.45%6.71%5.62%2.23%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

QLENX vs. CLOI - Drawdown Comparison

The maximum QLENX drawdown since its inception was -39.59%, which is greater than CLOI's maximum drawdown of -3.25%. Use the drawdown chart below to compare losses from any high point for QLENX and CLOI. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%NovemberDecember2025FebruaryMarchApril
-0.47%
-0.62%
QLENX
CLOI

Volatility

QLENX vs. CLOI - Volatility Comparison

AQR Long-Short Equity N (QLENX) has a higher volatility of 6.05% compared to VanEck CLO ETF (CLOI) at 4.04%. This indicates that QLENX's price experiences larger fluctuations and is considered to be riskier than CLOI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%1.00%2.00%3.00%4.00%5.00%6.00%NovemberDecember2025FebruaryMarchApril
6.05%
4.04%
QLENX
CLOI